Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence

Recruiting now

Conditions studied: Esophageal Atresia

In brief

Oesophageal atresia (OAEA), a malformation of the oesophagus present from birth, is characterized by the interruption of the continuity of the oesophagus, which then ends in a cul-de-sac. (Source: Fimatho) An operation is then required to restore continuity to the esophagus. Although this operation enables the vast majority of children to survive the neonatal period, health problems such as gastro-oesophageal reflux, eating difficulties, respiratory problems and growth problems persist throughout life. The aim of the project is to create a prospective cohort of adolescents aged 13/14, nested in the national AO registry. of adolescents born with esophageal atresia, including a biobank of esophageal mucosa and plasma blood samples. Once the clinical and omic data have been collected, the data will be transferred to the France Cohortes information system for analysis, in order to assess the long-term outcome of this rare disease and establish multi-omic profiles. Once the clinical data have been collected and the omics data (derived from analysis of the biobank's biological samples) have been generated, they will be analyzed by the project partners to assess the long-term outcome of OA and establish multiomic profiles. The raw data will be available on the France Cohorte platform.

Key facts

Study ID

NCT05995171

Run by

University Hospital, Lille

People needed

300

Starts

2023-11-14

Expected to finish

2026-11-14

Last updated by the study team

2026-04-22

Who can join

Age: 13 and older, up to 14. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• For the oesophageal atresia group :
• Born with oesophageal atresia (EA) in France or in French overseas departments and territories
• Anastomosis performed
• Included into the ReNaTo registry
• Aged 13 or 14 during the recruitment period
• Patient willing to comply with all study procedures and duration
• Patient will social security
• For the blood sub-study :
• Upper GI endoscopy performed as part of care between 13 and 14 years of age with esophageal mucosal biopsy sampling
• Patient having given written consent to participate in the study
• For the control arm:
• Upper GI endoscopy performed as part of care between 10 and 14 years of age with oesophageal mucosal biopsy sampling
• Upper GI endoscopy performed as part of care for chronic or acute digestive signs to rule out organic etiology (peptic esophagitis, gastric esophagitis, eosinophilic esophagitis or ulcer)
• Normal endoscopy and histology
• No chronic progressive disease

You may not qualify if…

• For the oesophagal atresia arm :
• Concurrent participation in an interventional trial and in the 3 months prior to inclusion
• Parents refusing to participate in the study
• For the control arm :
• Histologically non-normal esophageal biopsy
• Parents refusing to participate in the study
• Child with known organic pathology

Where it is running

• CHU Dijon — Dijon, France (enrolling)
• CHU Bordeaux — Bordeaux, France (enrolling)
• HLC Hôpital Mère Enfant — Bron, France (enrolling)
• AP-HP Hôpital Necker — Paris, France (enrolling)
• AP-HP Hôpital Robert Debré — Paris, France (enrolling)
• CHU Poitiers — Poitiers, France (enrolling)
• CHU Caen — Caen, France (enrolling)
• CHU de Rennes — Rennes, France (enrolling)
• CHU Angers — Angers, France (enrolling)
• AP-HM Hôpital La Timone — Marseille, France (enrolling)
• CHU Montpellier — Montpellier, France (enrolling)
• CHI Créteil — Créteil, France (enrolling)
• CHU Nantes — Nantes, France (enrolling)
• CHU Fort de France — Fort-de-France, Martinique (enrolling)
• CHU de Lille Hôpital Jeanne de Flandre — Lille, Nord, France (enrolling)
• CHU Strasbourg — Strasbourg, France
• CHU Toulouse — Toulouse, France
• CHU Tours — Tours, France
• CHU de Saint Denis de la Réunion — Saint-Denis, Reunion
• CHU Amiens — Amiens, France
• CHU Besançon — Besançon, France
• CHU Clermont-Ferrand — Clermont-Ferrand, France
• CHU Grenoble — La Tronche, France
• AP-HP Hôpital Kremlin Bicêtre — Le Kremlin-Bicêtre, France
• CHU Le Mans — Le Mans, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.